Seven Eight Capital, LP Amarin Corp Plcuk Transaction History

Seven Eight Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$4.26 - $6.5 $48,138 - $73,450	-11,300 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$4.04 - $5.31 $45,652 - $60,002	11,300 New	11,300 $55,000
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $257,366 - $548,670	-70,705 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$4.78 - $8.26 $337,969 - $584,023	70,705 New	70,705 $489,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.